Font Size: a A A
Keyword [large B-cell lymphoma]
Result: 81 - 100 | Page: 5 of 10
81. Significance Of GSK-3β And β-catenin Protein Expression In The Tissues Of Diffuse Large B Cell Lymphoma
82. Study On The Role Of Interleukin-9in Diffuse Large B-cell Lymphoma
83. Treatment Outcomes And Dosimetric Evaluations In Patients With Primary Mediastinal Large B-cell Lymphoma Receiving Combined Modality Therapy And Intensity-modulated Radiotherapy
84. Study On Immunephenotype, Antiapoptotic Properties And PI3K/Akt/mTOR Signalling Mechanism In Uygur Diffuse Large B Cell Lymphoma In Xinjiang
85. Study Of Immunohistochemical Subgroups, Molecular Genetic Alterations And Their Correlations To Prognosis In Chinese Patients With Diffuse Large B Cell Lymphoma
86. The Regulatory Effect And Underlying Mechanism Of JMJD3in Promoting Progress Of Diffuse Large B-cell Lymphoma
87. Prognostic Values Of Novel Molecules In NF-κB Pathway Among Peripheral T Cell Lymphoma And Diffuse Large B Cell Lymphoma
88. The Role Of Molecular Pathogenesis Of The Activation Of PI3K/AKT/mTOR Signaling Pathway And The Pre-clinical Study Of Targeted Therapy In Diffuse Large B Cell Lymphoma
89. Clinical Studies Of Non-Hodgkins Lymphoma
90. The Impact Of Expression Of Costimulatory Molecules In Peripheral Blood T Cells Among The Patients With DLBCL
91. Analysis Of Primary Extranodal Non-Hodgkin Lymphomas Of The Oral Cavity
92. Prognostic Analysis Of HBV Infection In DLBCL And The Role Of T Cell-mediated Immunity
93. Investigation On Aberrant Expression Of PI3K Catalytic Subunits And AKT Activation In DLBCL
94. The Clinical And Experimental Study Of Mononuclear Phagocyte System In Diffuse Large B Cell Lymphoma
95. To Investigate The Prognosis In Diffuse Large B-cell Lymphoma And Etiology Of Non-Hodgkin Lymphoma
96. Clinical Application 18F-FDG PET/CT In The Prognostic Prediction Of Diffuse Large B-cell Lymphoma
97. Clinical Outcome And Dosimetric Analysis Of Radiotherapy For Patients With Waldeyer Ring Diffuse Large B-Cell Lymphoma
98. Research On Treatment And Prognosis Of Diffuse Large B-cell Lymphoma And T/NK Cell Lymphoma
99. The Detection Of Serum Light Chain In DLBCL And The Mechanism Of Benefiting Vital Energy And Eliminating Phlegm Prescription In Regulating The Growth Of DLBCL
100. Vernodalol Enhances TRAIL-induced Apoptosis In Diffuse Large B-cell Lymphoma Cells
  <<First  <Prev  Next>  Last>>  Jump to